Skin Symptoms and Patch Tests in 185 Lithuanian Metalworkers

November 10, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional workplace scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

This review asks one narrow workplace question and keeps the paper’s denominator, design, result and limitations attached. It is education, not a diagnosis or individualized occupational-safety plan.

What did the study actually examine?

Study element	Reported detail
Population	185 workers from two Lithuanian metal plants: 154 production workers and 31 office staff; 135 underwent patch testing.
Design	Cross-sectional interviewer questionnaire plus European-baseline-series patch testing.
Timepoint	Single workplace assessment.
Key result	Production workers younger than 40 and those with under 20 years in the factory reported more skin symptoms. Cobalt sensitization predominated in metalworkers, while nickel was most prevalent in office staff.
Funding/conflicts available in abstract	Funding or conflicts were not stated in the PubMed abstract.

How should the result be read?

Production workers younger than 40 and those with under 20 years in the factory reported more skin symptoms. Cobalt sensitization predominated in metalworkers, while nickel was most prevalent in office staff.

The key is to separate three different ideas: a symptom report, a clinician-confirmed dermatitis diagnosis and a positive allergy test. They are not interchangeable. A patch-test reaction indicates sensitization under test conditions; occupational relevance still depends on the exposure history, clinical pattern and timing.

Important limitation: Only 135 participants were patch tested, reported symptoms were not equivalent to diagnosed occupational dermatitis, and the abstract provides limited absolute counts.

What can a worker document before an appointment?

The exact task, material, cleanser, glove, resin, dye, metal, food, dust or equipment used.
Where symptoms appear, when they begin, and whether they change on days away.
Product labels and safety data—without placing workplace substances directly on the skin.
Required PPE, handwashing frequency, heat, friction, sweating and wet-work duration.
Changes in function, sleep, attendance or the ability to complete specific tasks.

Exposure controls, substitution, engineering measures and correctly selected protective equipment belong in the conversation with occupational health and the employer. Skin-care products do not replace those controls. Seek prompt medical care for severe pain, rapidly spreading redness, drainage, fever, breathing symptoms or major loss of function.

Primary research and guidance

PubMed indexing is not NIH endorsement of the study’s interpretation, this article or any product.

Where a cosmetic moisturizer fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine. This article makes no treatment, cure, prevention, itch-relief, pediatric-safety or 24-hour claim.

Bottom line

This evidence is most useful when its population, denominator and design travel with the number. Use it to sharpen questions about diagnosis, exposure and work design—not to promise that one routine works for every person or job.

← Back to Doctor's Notes